Dr. Ford Brewer MD MPH · 2026-07-30 · Ford Brewer (host), Jesus Vega, Olivia, Sam, Matthew, Tom, Mark

Stop Chasing Your Cholesterol Number And Look At Your Arteries!

19 research-tied claims examined: 2 contradicted 2 overstated 7 context 8 supported

2

Overstated

0:33:00Ford Brewer (host)overstatedhigh

In the Diabetes Prevention Program (DPP), a gentle lifestyle intervention was three times more effective than metformin.

"There was a study, the Diabetes Prevention Program (DPP), folks can look that up. It was very, very clear what it showed was lifestyle—just gentle, not incredible, but gentle lifestyle, including in terms of weight loss, it was like 5% of body weight, it wasn't huge; working out between one and two hours a week, and not significant workouts, not major intense workouts, some relatively mild workouts for an hour or two; doing those and some moderate changes on diet, not huge changes on diet. Those three components alone were three times more effective than metformin in the Diabetes Prevention Program." (said at 0:33:00)

In the landmark Diabetes Prevention Program (DPP) randomized controlled trial, the intensive lifestyle intervention reduced the incidence of type 2 diabetes by 58% compared with placebo, whereas metformin reduced incidence by 31%. While the lifestyle intervention was significantly more effective than metformin (approximately 1.9 times the relative risk reduction), it was not three times more effective.

0:37:15Ford Brewer (host)overstatedmoderate

The CAFE and CAPS studies demonstrated that CIMT (carotid intima-media thickness) predicts the risk of heart attack and stroke through soft plaque.

"Way back in the '80s and '90s when the CAFE / CAPS study came up and demonstrated that CIMT was a great way of predicting risk for heart attack, estimating risk for heart attack and stroke through soft plaque, a lot of people jumped on board." (said at 0:37:15)

The speaker's characterization is overstated and conflates several distinct concepts and studies. First, the Carotid Atherosclerosis Progression Study (CAPS) evaluated carotid intima-media thickness (cIMT) and found that while cIMT independently correlates with cardiovascular events, adding common cIMT to standard risk models did not meaningfully improve individual risk reclassification or prediction in the general population. Second, cIMT measures the combined thickness of the intimal and medial arterial wall layers (reflecting diffuse thickening/early vascular remodeling), which is biologically and methodologically distinct from focal carotid plaque or plaque echogenicity ('soft plaque'). Finally, the CAFE trial (Conduit Artery Function Evaluation) evaluated central aortic blood pressure and pulse wave hemodynamics in hypertension, not CIMT or soft plaque assessment.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.